Navigation Links
WaferGen Bio-systems and QIAGEN KK Sign Agreement for Co-Marketing in Japan
Date:2/19/2013

FREMONT, Calif., Feb. 19, 2013 /PRNewswire/ -- WaferGen Bio-systems, Inc. (OTCBB: WGBS) announced today a co-marketing agreement with QIAGEN KK – a subsidiary of QIAGEN N.V.– for the joint promotion of certain products in Japan in the areas of genomics platforms such as Next-Gen sequencing (NGS) and qPCR.  With the joint offering, customers will be able to seamlessly plan and execute complex research projects involving molecular biomarker discovery with NGS, where WaferGen's SmartChip will offer a powerful platform for high-throughput qPCR-based target validation.  The purpose of the commercial relationship is to help life science researchers accelerate the process of developing markers that are potential candidates for molecular diagnostics by adding WaferGen's SmartChip solution to facilitate biomarker validation.  Further customer-facing synergies will be achieved by offering QIAGEN's PCRarrays on the SmartChip and subsequently compatible NGS panels from QIAGEN.

Stephane Perrey , President of QIAGEN KK stated: "We are looking forward to expanding our portfolio of life science offerings in Japan through the co-marketing of WaferGen's high-throughput qPCR solution.  There is a substantial customer need to ramp up discovery efforts through targeted screening and confirmation, and our integrated approach will provide one-stop shopping for a variety of academic and industrial clients.  We will be able to guide customers through the series of steps necessary for an effective biomarker discovery and validation program, by providing both the instrumentation and assays necessary for the accomplishment of their scientific goals.  We have successfully evaluated WaferGen's SmartChip System, and we believe that it can play an important role in our comprehensive product offering."

"We are extremely pleased t
'/>"/>

SOURCE WaferGen Biosystems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
2. WaferGen to Present Corporate Overview at Oppenheimer Healthcare Conference
3. WaferGen to Present Corporate Overview at 5th Annual OneMedForum San Francisco 2012
4. WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment
5. WaferGen Bio-systems Awarded 1 Million Euro Grant by the Luxembourg Government to expand its European Operations
6. WaferGens MyDesign Open Platform Facilitates Rapid Development of a Proprietary Prostate Cancer Diagnostic Panel in the Lab of Dr. Arul Chinnaiyan at the University of Michigan Cancer Center
7. QIAGEN and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals With Latent Infection
8. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
9. BioHealth Innovation, Inc. Appoints Qiagens Douglas Liu to Board of Directors
10. QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to Worlds Poorest Countries
11. QIAGEN Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... July 03, 2015 , ... The ... companies and professional service industries alike-- typically known for its consummate professionalism-- embarks ... a good cause and break from their day jobs. , "Our motto has ...
(Date:7/3/2015)... , July 3, 2015 ... den 22. september 2015 på  http://www.openinnovationinscience.at ... Science", der finder sted i ... nylig undersøgelse af internationale forskere og videnskabsmænd ... de to største udfordringer for sundhedsvidenskaben manglen ...
(Date:7/2/2015)... , ... July 02, 2015 , ... Sleepless nights will ... individual’s quality of sleep, launched its Indiegogo campaign on June 23. Sound sleepers and ... command technology makes it effortless to use, while the integration of the Bluetooth speaker, ...
(Date:7/1/2015)... ... July 01, 2015 , ... The next-generation sequencing (NGS) clinical ... segments, including the molecular diagnostics industry. BCC Research reveals in its new report that ... lower test costs, and a growing need for better diagnostics as part of a ...
Breaking Biology Technology:The Alexander Group Declares Their Independence with a Bit of Levity 2Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 2Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 3Luzi Smart Lamp Recently Launched Indiegogo Campaign 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 3NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3
... RUTHERFORD, N.J., Nov. 3, 2010 Cambrex Corporation (NYSE: ... 30, 2010. Highlights ... currency, sales decreased 11.5% compared to third quarter 2009.   ... to $11.0 million in the same quarter last year. Debt, ...
... Nov. 3, 2010 Advanced Life Sciences ... a biopharmaceutical company engaged in the discovery, development and commercialization ... and respiratory diseases, today announced that the Company has been ... which was created by Congress as part of the Patient ...
... Board: CVAT, Berlin & Stuttgart: WTC) proudly announces that its ... Exchange under the ticket symbol WTC. CTI,s ... with the listing on the Frankfurt Stock Exchange to help ... visibility and support in the European market.  The listing on ...
Cached Biology Technology:Cambrex Reports Third Quarter 2010 Results 2Cambrex Reports Third Quarter 2010 Results 3Cambrex Reports Third Quarter 2010 Results 4Cambrex Reports Third Quarter 2010 Results 5Cambrex Reports Third Quarter 2010 Results 6Cambrex Reports Third Quarter 2010 Results 7Cambrex Reports Third Quarter 2010 Results 8Cambrex Reports Third Quarter 2010 Results 9IRS Awards Cash Grant to Advanced Life Sciences Under the Qualifying Therapeutic Discovery Project 2IRS Awards Cash Grant to Advanced Life Sciences Under the Qualifying Therapeutic Discovery Project 3Listing on Frankfurt Stock Exchange for CTI (http://ctinanotech.com) 2Listing on Frankfurt Stock Exchange for CTI (http://ctinanotech.com) 3
(Date:6/25/2015)... , June 25, 2015 ... Market by Type (Swipe & Area), Technology, Material (Optical ... Healthcare, Commercial Security & Others) & Geography - ... marketsandmarkets, the said market is expected to reach ... 17.1%. Browse 76 market Tables ...
(Date:6/25/2015)... -- TAKE Solutions Ltd., a global business technology solutions provider, ... and Trademark Office (USPTO) for its "Method for Optimizing ... Accelerators to reduce the time taken to standardize trial ... the accelerators), thus reducing time to market. ... heart of the patented Clinical Data Standardization Process are ...
(Date:6/24/2015)... , June 24, 2015 This report provides ... the next six years. It contains an analysis of ... along with their impact from the short, medium, and ... discusses the industry, market, and technology trends that currently, ... need of concerned authorities to efficiently manage the increasing ...
Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4TAKE Solutions Awarded Patent By USPTO 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2
... 2011, a team of Chinese and Swedish researchers rediscovered the ... , in the Qinling mountains, Shaanxi province, north central China. ... more in Changqing National Nature Reserves which almost equals ... its discovery in the late 19th century. Nearly all of ...
... a protein that is associated with the spread of cancer ... in chemistry one of this year,s Kaye Innovation Awards at ... a student of Prof. Chaim Gilon and Prof. Alexander Levitzki ... Protein Kinase B (PKB, also called Akt). Since the activation ...
... Inc. (Ticker: MDBX) ( www.medboxinc.com ) today announced their ... Prescription Vending Machines, Inc. (PVM). PVM,s ... appointees by stating, "I am thrilled to have such ... Doctorates and MBAs. We are entering a period of ...
Cached Biology News:Sensational bird finding in China 2Sensational bird finding in China 3Medbox, Inc. Announces New Board of Directors After Acquisition of Prescription Vending Machines, Inc. 2
This free-standing work station safely ventilates fumes upwards, away from the work surface. Optional Exhaust Purification System features bonded charcoal filters that remove organic chemical vapors ...
... Analysis Note: Protein determined by ... 3.2 M (NH 4 ) ... 7.0 Preparation Note: Affinity purified ... suspension • Additives: MgCl 2 ...
... miRNA Bioarray Essentials Kit provides all the necessary ... of the mir Vana miRNA Bioarrays when ... using Ambions mir Vana miRNA Labeling Kit. ... (Bioarray ID BA10001) that should be spiked into ...
... IT siRNA Tracker Intracellular Localization Kit ... straight forward approach to directly label ... in an efficient yet non-destructive manner, ... localization and functional inhibition of target ...
Biology Products: